And sold for a very tiny profit. $NVDA GTC next week is a catalyst but going risk-off again as I think the Iran war drags on for a bit.

150 would be 18 P/E for this year. Actual P/E would be below that if any China sales happen.

You think $NVDA valuation crush really goes that low?

Added $NVDA shares as estimates for this year moved from 7.66 to 8.26 putting the stock at 22 forward P/E. Think the selloff is trauma from last ER.

And once again out of the market. Don't want to hold through the sky high $NVDA earnings expectations. So selling into this strength and will just hold cash for the moment.

Went long the market on the surprise tariff ruling. Bought $AMZN, $MSFT, $IGV, and /MNQ. It dropping on OPEX that can lead to reversals of fortunes for the next month means I'm swapping to try being bullish. Narratives drive markets and the one forming should be +equities, -long duration bonds.

Sold. Diversifying saved me from a loss thanks for $NVDA outperformance despite the $AMZN ER reaction. If accelerating growth is bearish due to the capex that causes, then really not a good time to be in most stocks.

Bought $MSFT LEAPS and shares in $AMZN + $NVDA. Just based on vibes finally feeling negative based on the JOLTS print today. May not be a bottom but I'm not expecting us to enter midterms with these at current levels.

Sold out of $MSFT and $NVDA this morning for a small profit overall. Likely back to bonds for me. Stocks just aren't reacting to positive news and it just seems like multiple compression is the game right now.

Rotated about half of this into $MSFT. I think the earnings were good personally.

Added a small position of $ORCL shares as datacenter builders seem to bottoming for the moment. May as well own the one of the group that has a legacy business that makes money.

Yeah, had thought the same actually and expected it to go lower as good news failed to pop it. May yet go down and would just add more at that level. Just confirmation sales improved further means I'm fine holding until that turns into new official guidance or earnings estimates move up.

Probably going to get burned but re-added some $NVDA. Forward P/E has been cheaper than normal but there is always risk of some insider bad news that has kept the stock down. Instead price remains flat as $NVDA says their previous guidance that was 50% above consensus is now again too low...

Sold here and took my profit. No need to be greedy.

In $NVDA and $AMZN for next year. Also have some $SPX 6950/7000 spreads for December 31.

AI selloff continues to get stupider. Today's catalyst is $ORCL going with a different financer for a site that is still being built. Could continue but I'll take $NVDA at 22.5 forward P/E.

OpenAI’s GPT-5.2 ‘code red’ response to Google is coming next week GPT-5.2 could arrive on December 9th

scoop: OpenAI’s GPT-5.2 "code red" response to Google is coming next week. I'm hearing that GPT-5.2 should drop on December 9th, slightly earlier than OpenAI was originally planning. Details here 👇 www.theverge.com/report/83885...

Unsure. Not even sure why others recovered when ACA extension is still likely to not occur despite recent headlines. I do recall $MOH is the most Medicaid focused that remains gutted from the BBB bill and that funding hole looks to remain going forward.

Well this didn't work out. Exited positions.

Picked up some $NVDA, $META, and $AMZN shares. Also some /MNQ contracts.

Had closed these shortly after open as the government shutdown resolution catalyst played out.

Bought $NVDA and $META shares. Also some $SPX December 19th call spreads.

Government shutdown eventually ends as a catalyst at some point and AI bubble should continue yet.

Bought some $NVDA shares now that it is sub-$200.

And back into $AMZN 2028 Leaps. Tariff news with China wasn't negative over the weekend like I expected and $AMZN remains the Megacap laggard.

Closed these positions. Could be we rally more but seems like a good moment to sell.

Added $AMZN January 2028 calls and some $META shares.

Sold these positions today as they have gone up all week. I believe the shutdown doesn't resolve quickly and healthcare has now run-up quite a bit.

Re-added positions in $ELV, $CNC, and $MOH. There is expected to be an announcement today of a Medicaid drug deal with Pfizer. Additionally, while a government shutdown looks likely, it some type of ACA subsidy extension will eventually happen based on recent comments.

Sold out of my healthcare insurance stocks ($ELV and $CNC). Not liking the price action nor new pharmaceutical tariffs.

$ELV bleed program continues. (Deep ITM put volume that never translates to open interest the next day). For today, it was 550 410p and 395 430p:

Any thoughts as to why this would be done? I am missing how this is profitable or what the point would be?

Best guess is that this is the "semis bottom on bad earnings" type saying being applied to healthcare. Those still left to report won't be as terrible as $CNC earnings + guide down was.